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Guo J, Williams DJ, Ikeda SR. N-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca 2ϩ channels in sympathetic neurons. J Neurophysiol 100: 1147 -1151 , 2008 . First published January 30, 2008 doi:10.1152 /jn.01204.2007 . The effect of N-arachidonoyl L-serine (ARA-S), a recently discovered lipoamino acid found in the CNS, on N-type Ca 2ϩ channels of rat sympathetic ganglion neurons was determined using whole cell patch clamp. Application of ARA-S produced a rapid and reversible augmentation of Ca 2ϩ current that was voltage dependent and resulted from a hyperpolarizing shift in the activation curve. ARA-S did not influence G protein modulation of Ca 2ϩ channels and appeared to act independently of G-protein-coupled receptors. These findings provide a foundation for investigating possible roles for ARA-S in nervous system function.
I N T R O D U C T I O N
Endocannabinoids comprise a group of endogenously produced lipid-derived molecules that bind to and affect CB 1 and CB 2 G-protein-coupled cannabinoid receptors. The best-characterized endocannabinoids, 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide), act as agonists at both CB 1 and CB 2 receptors and are implicated in a variety of physiological responses . In addition to receptor-mediated effects, endocannabinoids interact directly with voltage-and ligand-gated ion channels producing alterations in gating usually manifested as channel inhibition (Oz 2006) . Recently, a novel endocannabinoid-like compound, N-arachidonoyl L-serine (ARA-S), was identified in extracts of bovine brain and shown to produce endotheliumdependent vasodilation of rat mesenteric arteries (Millman et al. 2006) . Synthetic ARA-S has minimal activity at traditional endocannabinoid targets (CB 1 R, CB 2 R, and TRPV1 channels) but appears to act via a novel, but as yet unidentified, G-protein-coupled non-CB 1 /CB 2 cannabinoid receptor. ARA-S is also reported to be an antagonist at a non-CB 1 /CB 2 cannabinoid receptor found in neutrophils (McHugh et al. 2007 ). While screening GPR35 (Guo et al. 2008) , an orphan G-proteincoupled receptor, as a potential target of ARA-S, we found that ARA-S produced receptor-independent effects on the activation of N-type Ca 2ϩ channels (Ca V 2.2) in rat sympathetic neurons leading to an enhancement of current especially at hyperpolarized potentials.
M E T H O D S

Cell isolation and electrophysiology
Superior cervical ganglion (SCG) neurons from male Wistar rats (150 -300 g) were enzymatically dissociated and placed in short-term (Ͻ24 h) culture as described previously (Ikeda 2004) . For some experiments, the neurons were incubated overnight in tissue culture media containing 500 ng/ml Bordetella pertussis toxin (PTX; List Biological Laboratories, Campbell, CA) as previously described (Guo and Ikeda 2004) . Rats were killed by decapitation after anesthesia with CO 2 as approved by the Institutional Animal Care and Use Committee. Neurons were voltage-clamped using the whole cell patch-clamp technique as described previously (Guo and Ikeda 2004) . I Ca tail currents were filtered at 10 kHz prior to digitization at 50 kHz. Series resistance was electronically compensated Ն80%. Experiments were carried out at room temperature (22-26°C).
Solutions and chemicals
The external recording solution contained (in mM) 140 methanesulphonic acid, 145 tetraethylammonium hydroxide, 10 HEPES, 10 glucose, and 10 CaCl 2 and 0.0003 tetrodotoxin (Alomone Labs, Jerusalem, Israel), pH 7.4 with TEA-OH. For tail current experiments, the CaCl 2 was reduced to 5 mM. The pipette solution contained (in mM) 120 N-methyl-D-glucamine, 20 tetraethylammonium hydroxide, 11 EGTA, 10 HEPES, 10 sucrose, 10 HCl, 1 CaCl 2 , 4 MgATP, 0.3 Na 2 GTP, and 14 Tris creatine phosphate, pH 7.2 with methanesulphonic acid. The osmolalities of the bath and pipette solutions were adjusted with sucrose to 325 and 300 mOsmol/kg, respectively. -arachidonoyl-L-Serine, and N-arachidonoyl-dopamine (ARA-DA) were purchased from Cayman Chemical (Ann Arbor, MI) as ethanol stock solutions (25-140 mM) and dissolved directly into the recording solution on the day of the experiment. Ethanol was Ͻϭ0.1% in all solutions and at this concentration produced no discernable effect on I Ca . Drugs were applied by positioning the outlet tube (200 m ID) of a custom-designed gravity-fed microperfusion system ϳ100 m from the cell body.
R E S U L T S
We tested the effect of ARA-A, ARA-G (Huang et al. 2001) , ARA-S, and ARA-DA (Huang et al. 2002 ) application on Ca 2ϩ currents (I Ca ) recorded from dissociated adult rat sympathetic neurons using whole cell patch clamp. Under these recording conditions, I Ca arises primarily from -conotoxin GVIA-sensitive N-type Ca 2ϩ channels (Ikeda 1991) . Currents were evoked with a 25-ms test pulse to Ϫ10 mV from a holding potential of Ϫ80 mV. Application of ARA-A (10 M) or ARA-S (10 M) produced a rapid and reversible enhancement of I Ca amplitude (Fig. 1A) without overt modification of I Ca kinetics (Fig. 1B) . Conversely, application of ARA-DA (10 M) to the same neuron produced minimal effects. A second series of sequential drug applications produced similar effects indicating that the minuscule ARA-DA response did not result from tachyphylaxis. ARA-G (10 M) was tested in a separate set of experiments and produced results similar to those observed following ARA-S application (Fig. 1C) . Comparison of the average change in I Ca amplitude (Fig. 1C) revealed that ARA-S produced the largest increase (132 Ϯ 14%, n ϭ 14) and thus further experiments focused on this compound.
The effect of ARA-S at different potentials was examined by evoking I Ca with 70-ms test pulses over the range Ϫ60 to ϩ80 mV from a holding potential of Ϫ80 mV in the presence or absence of 10 M ARA-S (Fig. 1D) . Under control conditions, I Ca became apparent around Ϫ30 mV, reached a maximum amplitude near ϩ10 mV, and thereafter declined asymptotically toward baseline. In the presence of ARA-S, I Ca was augmented several-fold at negative test potentials with lesser increases at more depolarized potentials. At very depolarized test potentials (Ͼ ϩ40 mV), I Ca amplitude was minimally affected, suggesting that a shift in Ca 2ϩ channel activation (Fig. 1E ) rather than an increase in the number of available channels was responsible for the action of ARA-S. A concentration-response curve for ARA-S is illustrated in Fig. 1F . Three concentrations of ARA-S (0.1, 1.0, and 10 or 0.3, 3.0, and 30 M) were applied to neurons allowing time to recover between each concentration. Potentiation of I Ca amplitude was evident starting at 3 M and increased monotonically without evidence of saturation Յ30 M, the highest concentration examined.
To investigate shifts in channel activation, Ca 2ϩ channel tail current amplitudes were determined in the absence or presence of ARA-S (10 M). Tail currents result from the deactivation of channels on return to a hyperpolarized potential following a sojourn at a step potential that produces channel activation ( Fig. 2A) . Because tail currents are measured at a constant potential (here Ϫ40 mV), driving force, which is nonlinear for large ionic gradients such as Ca 2ϩ , remains constant and thus I Ca amplitude can be equated with conductance. To facilitate accurate tail current measurement, analog filter bandwidth (Ϫ3 dB) and digital sampling rate were increased to 10 and 50 kHz, respectively. External [Ca 2ϩ ] was decreased to 5 mM, which served to decrease tail current amplitude and hence the effects of residual uncompensated series resistance. Under these conditions, tail current decays were well fit (following a 100-s delay to allow uncompensated capacitive transients to settle) by a single-exponential function (Fig. 2B, -) with of ϳ0.5 ms. Activation curves were plotted as tail current amplitude, normalized to maximum amplitude (e.g., ϩ80-mV step potential) in the absence of drug, versus step potential (Fig. 2C) and fit (-) with a two-component modified Boltzmann equation
where I tail is the normalized tail current amplitude and V step is the step potential. I n , V hn , and k n are the fractional amplitude, half activation potential, and slope factor, receptively for each component. Under control conditions, Ca 2ϩ channel activation curves from adult rat SCG neurons are composed of two components-a result of tonic G protein modulation (Ikeda 1991) . In the presence of ARA-S, the activation was shifted toward more hyperpolarized potentials, retained a two-component profile, and achieved a similar maximum amplitude. ] was decreased to 5 mM to reduce current amplitude thereby reducing series resistance error. B: tail current decay illustrated on an expanded time scale (same traces as in A). The initial 100 s following the step pulse have been blanked. -, nonlinear least-square fits to single-exponential function. C: activation curves composed of mean Ϯ SE (n ϭ 5) normalized tail current amplitudes vs. step potential. Tail current amplitudes were determined from the exponential fit of the tail current decay phase. Amplitudes obtained in the absence (E) or presence (F) of ARA-S were normalized to the maximum amplitude in the absence of drug. -, the best fit of a 2-component Boltzmann equation (see text) to the data using nonlinear least-squares regression. D: voltage dependence of ARA-S effects illustrated by plotting the ratio of I Ca amplitude in the presence of ARA-S to the control condition for step (ᮀ) and tail currents (■) vs. step potential. E: table of mean Ϯ SE Boltzmann equation parameters. A paired t-test was used for statistical comparison between the control and drug condition. ***, P Ͻ 0.001; *, P Ͻ 0.05.
Analysis of the activation parameters (Fig. 2E ) revealed significant decreases in V h1 , V h2 , and k 2 but no change in the fractional contribution of each component. The hyperpolarizing shift in the activation curve account for the voltagedependent I Ca increases as shown in Fig. 2D . Both the tail and step I Ca were affected to a much greater extent by ARA-S at hyperpolarized voltages. The coincidence of the step and tail I Ca data in Fig. 2D provide evidence for the fidelity of the tail current recordings.
Next, we asked whether ARA-S affects I Ca modulation by G-protein-coupled receptors. In SCG neurons, norepinephrine (NE) acts by binding to ␣ 2 -adrenergic receptors (Schofield 1990 ) thereby liberating G␤␥ from the heterotrimeric G protein complex resulting in voltage-dependent modulation (Bean 1989; Ikeda 1996) . This form of I Ca modulation is detected using a double-pulse voltage protocol (Elmslie et al. 1990 ) (Fig. 3B ) in which two identical test pulses to ϩ10 mV are separated by a depolarizing conditioning pulse to ϩ80 mV. Facilitation, defined as the ratio of postpulse to prepulse I Ca amplitude, provides a convenient index of G␤␥-mediated modulation (Fig. 3A) . Increases in facilitation result from relief of G␤␥ inhibition produced by the conditioning pulse. Application of NE produced I Ca inhibition with a coincidental increase in facilitation that was similar in the presence of ARA-S. The mean inhibition of I Ca , basal (i.e., in the absence of agonist) facilitation, and NE-induced facilitation were significantly different in the presence of ARA-S (Fig. 3C) . However, the magnitude of the changes were small and possibly arose from effects of ARA-S on minor components of I Ca that do not arise from N-type Ca 2ϩ channels. Thus ARA-S does not appear to greatly influence either receptor-mediated or tonic modulation of N-type Ca 2ϩ channels by G␤␥. The effects of ARA-S (10 M) on neurons treated overnight with 500 ng/ml PTX were also examined. I Ca potentiation following ARA-S application was not significantly altered by pretreatment with PTX (210 Ϯ 4, n ϭ 3 vs. 290 Ϯ 31%, n ϭ 9 for control and PTX-treated, respectively). Conversely, NE-mediated I Ca inhibition was decreased (13 Ϯ 6, n ϭ 3 vs. 52 Ϯ 3%, n ϭ 9, for PTX and control, respectively) following PTX treatment providing evidence for toxin effectiveness. Thus activation of PTX-sensitive G proteins, namely G i/o -containing heterotrimers, were not essential for I Ca increases resulting from ARA-S application.
D I S C U S S I O N
Our data show that ARA-S produces a rapid and reversible augmentation of I Ca in sympathetic neurons that is voltage dependent and results from a hyperpolarizing shift in the activation curve. At depolarized potentials, the same maximal conductance is attained in the presence of ARA-S arguing against a recruitment of covert channels or a change in the maximum probability of opening. ARA-S did not interfere with or contribute to G protein modulation of N-type Ca 2ϩ channels. We thus conclude that I Ca enhancement by ARA-S occurs independently of G-protein-coupled receptors and possibly results from direct interaction with the Ca V 2.2 channel or alteration of plasma membrane surface potential.
There are two main implications of these findings. First, the ARA-S concentration (10 M) used here falls well within the concentration range used to probe potential physiological roles of ARA-S and related endocannibinoids (Milman et al. 2006) . Given the well-established role played by N-type Ca 2ϩ channels in providing Ca 2ϩ for synaptic transmission combined with the nonlinear relationship between [Ca 2ϩ ] and transmitter release (Xu et al. 2007) , one can easily envision changes in synaptic transmission produced by applying ARA-S. Thus receptor-independent effects, such as the one demonstrated here, will need to be considered before meaningful interpretations of ARA-S action are entertained. Although agents such as Bordetella pertussis toxin are useful for separating receptordependent (at least in terms of GPCRs using G i/o ␣-containing heterotrimers) from receptor-independent effects, this ability degrades as the complexity of the system increases (e.g., in vivo experiments). Second, it is possible that direct actions of ARA-S on ion channels underlie physiological processes. For example, a related compound, anandamide, is proposed to influence physiological function by binding to CB 1 R/CB 2 R and subsequently activating downstream signaling cascades or directly activating TRPV channels without the aid of signaling intermediates (Smart et al. 2000; van der Stelt and Di Marzo 2005; van der Stelt et al. 2005) . Although endocannabinoids and related lipid compounds (Bradshaw and Walker 2005) often have direct effects on ion channel function (Oz 2006) , the effect of ARA-S on N-type Ca 2ϩ channels is somewhat unique. Closely related compounds such as anandamide, 2-AG (Guo and Ikeda 2004) and ARA-DA (Fig. 1C) either have no effect or produced inhibition at similar concentrations, whereas both ARA-A and ARA-G were capable of augmenting I Ca to varying degrees (Fig. 1C) . From this series of compounds, the presence of a carboxylic acid group was common to the substances that enhanced I Ca amplitude. We could not find literature values for the pK a of ARA-S or related lipoamino acids thus the charge status of the carboxylic acid group at physiological pH is unclear. Given the pK a of the carboxylic acid group in the free amino acids (2.1-2.4), it seems likely that ARA-S, ARA-G, and ARA-A are negatively charged at pH 7.4. Thus a possible explanation for the effects of ARA-S and related lipoamino acids is alteration of the membrane surface potential (Hille 2001 ) following incorporation of negative charges into the outer leaflet of the plasma membrane. The net result would be a negative shift in channel activation as seen following ARA-S application. It should be noted, however, that enhancement of L-type I Ca in ventricular myocytes by long chain fatty acids occurred without shifting activation or inactivation along the voltage axis (Huang et al. 1992 ) thus arguing against this explanation as a universal mechanism for Ca 2ϩ channel modulation by negatively charged lipophilic agents.
The actions of ARA-S are somewhat reminiscent of the effects of arachidonic acid on N-type Ca 2ϩ channels in SCG neurons (Liu and Rittenhouse 2003; Liu et al. 2001) . Although ARA-S, a conjugate of arachidonic acid and serine, likely breaks down to arachidonic acid, ARA-S lacks a Ca 2ϩ channel inhibitory component characteristic of arachidonic acid effects. Therefore, it is unlikely that arachidonic acid mediates the effects of ARA-S although we cannot conclusively rule out this possibility. The stimulatory effects of ARA-S on N-type Ca 2ϩ channels are strikingly similar to those observed for the fatty acid analogs palmitoyl coenzyme A and arachidonoyl coenzyme A . Thus the lipid moiety in these compounds may share a common mechanism for Ca 2ϩ channel stimulation that is conferred by the charge on the head group. At present, many details relevant to the biology of ARA-S, including synthetic and degradative pathways, partition coefficient, and sites of action have not been investigated. This void in our knowledge limits speculation as even fundamental facts, such as the relevant physiological concentration of ARA-S, remain unknown. 
